To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

Primary Objectives:

To assess the influence of smokeless tobacco products' modified risk claims on:

1. Product demand (measured as willingness to pay in USD) using an experimental auction approach; and
2. Perceived risk of tobacco-associated diseases as assessed using questionnaire-based measures.

Inclusion Criteria:

• Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
• Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
• Open to trying a non-combusted oral tobacco product.
• Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
• Have the ability to read, write, and communicate in English.
• Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure

Exclusion Criteria:

• Plan to quit smoking in the next 30 days.
• Use of smokeless tobacco at least weekly in the last 6 months.
• Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
• Unwilling or unable to follow protocol requirements.
• Pregnant or planning to become pregnant (by self report)